cis-Cyclopentane-1,3-diamine dihydrochloride

Catalog No. :
ACRNJH328
CAS No. :
63591-57-1
Molecular Formula :
C5H14Cl2N2
Molecular Weight :
173.09

IUPAC Name:(1R,3S)-cyclopentane-1,3-diamine dihydrochloride

cis-Cyclopentane-1,3-diamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$74.00Login to see priceIn stockIn stock
250mg95%$117.00Login to see priceIn stockIn stock
1g95%$272.00Login to see priceIn stockInquiry
5g95%$1348.00Login to see priceIn stockInquiry
25g95%$5364.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-Cyclopentane-1,3-diamine dihydrochloride
IUPAC Name(1R,3S)-cyclopentane-1,3-diamine dihydrochloride
MDL No.MFCD13184826
Molecular FormulaC5H14Cl2N2
Molecular Weight173.09
SMILESN[C@H]1C[C@@H](N)CC1.[H]Cl.[H]Cl
InChI KeyUQEZIVFRVHUPSU-QGAATHCOSA-N
Synonymcis-Cyclopentane-1,3-diaMine dihydrochloride;(1R,3S)-cyclopentane-1,3-diamine dihydrochloride;1,3-Cyclopentanediamine, hydrochloride (1:2), (1R,3S)-rel-;Cyclopentane-1,3-diamine dihydrochloride, cis;1,3-Cyclopentanediamine, dihydrochloride, cis-;cis-1,3-Cyclopentanediamine dihydrochloride
CAS No.63591-57-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRNJH328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMRWI521 route compound structure diagram
    ACMRWI521454709-98-9 In Stock
  2. Then
  3. ACRNJH328 route product structure diagram
    ACRNJH32863591-57-1 In Stock
Inquiry

2. ACRNJH328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEQEE106 route compound structure diagram
    ACEQEE1062459946-28-0 In Stock
  2. Then
  3. ACRNJH328 route product structure diagram
    ACRNJH32863591-57-1 In Stock
Inquiry

Comments (0)